Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million - TradingView — Track All Markets

Reuters | Dec. 15, 2025, 8:13 a.m. | Original
Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million TradingView — Track All Markets
Mackenzie Investments Announces December 2025 Quarterly Distributions - TradingView — Track All Markets Netflix says its position on deal with Warner Bros Discovery unchanged - TradingView — Track All Markets